US Pre-Market SEC Filings Roundup — September 24, 2026

23-09-2026

Chief Strategy Officer Kang Daniel bought 6,900 Variable Rate Series C Perpetual Preferred Stock at $8.84 (~$61K). Kang Daniel holds 3,540 shares after the transaction.

• · Chief Strategy Officer Kang Daniel bought 6,900 Variable Rate Series C Perpetual Preferred Stock at $8.84 (~$61K)
• · Chief Strategy Officer Kang Daniel bought 3,540 Variable Rate Series C Perpetual Preferred Stock at $8.81 (~$31.2K)

23-09-2026

Director KAMFAR RAMIN acquired 111,885 Common Shares of Beneficial Interest at $12.02 (~$1.34M). 4 transactions reported in total. KAMFAR RAMIN holds 1,935 shares after the transaction.

• · Director KAMFAR RAMIN acquired 67,878 Common Shares of Beneficial Interest at $11.96 (~$812K)
• · Director KAMFAR RAMIN acquired 67,878 Common Shares of Beneficial Interest at $11.96 (~$812K)
• · Director KAMFAR RAMIN acquired 111,885 Common Shares of Beneficial Interest at $12.02 (~$1.34M)
• · Director KAMFAR RAMIN acquired 111,885 Common Shares of Beneficial Interest at $12.02 (~$1.34M)

23-09-2026

Director Ang Andrew acquired 15,000 Class B Ordinary Shares at $0.01 (~$90).

• · Director Ang Andrew acquired 15,000 Class B Ordinary Shares at $0.01 (~$90)

23-09-2026

Deputy Ch Ex Off & Ch Oper Off Rizzotti Elisabeth was awarded 96,140 Stock Options (Right to Buy). 5 transactions reported in total.

• · Deputy Ch Ex Off & Ch Oper Off Rizzotti Elisabeth was awarded 96,140 Stock Options (Right to Buy)
• · Deputy Ch Ex Off & Ch Oper Off Rizzotti Elisabeth was awarded 3,759 Stock Options (Right to Buy)
• · Deputy Ch Ex Off & Ch Oper Off Rizzotti Elisabeth was awarded 7,416 Stock Options (Right to Buy)
• · Deputy Ch Ex Off & Ch Oper Off Rizzotti Elisabeth was awarded 12,418 Stock Options (Right to Buy)
• · Deputy Ch Ex Off & Ch Oper Off Rizzotti Elisabeth was awarded 32,447 Class B Shares

23-09-2026

10% owner HARARI ELIYAHOU ET AL bought 878,735 Common Stock at $5.69 (~$5M). HARARI ELIYAHOU ET AL holds 878,734 shares after the transaction.

• · 10% owner HARARI ELIYAHOU ET AL bought 878,735 Common Stock at $5.69 (~$5M)
• · 10% owner HARARI ELIYAHOU ET AL bought 878,734 Common Stock at $5.69 (~$5M)

23-09-2026

Director Alford Tony L bought 1,000 Common Shares at $4.36 (~$4.36K). Alford Tony L holds 3,178,056 shares after the transaction.

• · Director Alford Tony L bought 1,000 Common Shares at $4.36 (~$4.36K)

23-09-2026

Head of Brand Center Bernes Marshall sold 15,703 Class A Ordinary Shares, par value $0.05 per share at $53.58 (~$841K). Bernes Marshall holds 25,447 shares after the transaction.

• · Head of Brand Center Bernes Marshall sold 12,000 Class A Ordinary Shares, par value $0.05 per share at $53.47 (~$642K)
• · Head of Brand Center Bernes Marshall sold 15,703 Class A Ordinary Shares, par value $0.05 per share at $53.58 (~$841K)

23-09-2026

Director Bliss Andrew sold 108,200 Ordinary Shares at $40.79 (~$4.41M). Bliss Andrew holds 4,794,873 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

• · Director Bliss Andrew sold 76,953 Ordinary Shares at $40.20 (~$3.09M)
• · Director Bliss Andrew sold 108,200 Ordinary Shares at $40.79 (~$4.41M)
• · Director Bliss Andrew sold 59,976 Ordinary Shares at $40.22 (~$2.41M)

23-09-2026

Form 4 ownership filing; the structured EDGAR document could not be retrieved for automated parsing.

23-09-2026

Director FONG GIFFORD bought 100 COMMON STOCK at $211.70 (~$21.2K). FONG GIFFORD holds 54,464 shares after the transaction.

• · Director FONG GIFFORD bought 100 COMMON STOCK at $211.70 (~$21.2K)

23-09-2026

Inflection Point Acquisition Corp. VII (IPAC) filed a 425 communication in connection with its proposed business combination with Elroy Air, Inc., a developer of autonomous hybrid-electric cargo drones. The filing includes a transcript from Elroy Air's Virtual Analyst Day on September 21, 2026, where management highlighted a commercial pipeline of over 1,400 units from customers including FedEx and Bristow Group, and a total addressable market of nearly $500 billion. However, the company has raised only $175 million over 10 years and has not disclosed current revenue figures, indicating early-stage commercialization with significant execution risk.

• · Elroy Air was founded in 2016 and has raised $175 million over 10 years.
• · The Chaparral drone has a payload capacity of 500+ pounds and a range of up to 450 miles.
• · The company has a commercial pipeline of over 1,400 units from customers including FedEx, Bristow Group, and Barq Group.
• · Defense partners include US Army, US Marine Corps, US Air Force, US Navy, and Japanese Army.
• · The company has a 220-year cumulative experience defense advisory board including former Secretary of Defense Mark Esper.
• · Kratos is partnered for high-volume manufacturing of Chaparral.
• · Elroy Air operates as an OEM with a revenue model focused on upfront sales and high-margin recurring revenue from software subscriptions, maintenance, and pods.
• · The company began operations in Louisiana under the FAA eVTOL integration pilot program a few months prior to the presentation.
• · CEO Andrew Clare previously led the Model X program at Tesla and was CTO at Nuro.
• · Founder Dave Merrill previously sold a startup to 3D Robotics.

24-09-2026

Banco Santander, S.A. disclosed a series of share repurchases totaling 10,900,000 shares across multiple trading venues between September 17 and September 23, 2026. The weighted average prices ranged from €12.5928 to €12.9668 per share, with the bulk of purchases occurring on September 18 and September 23. The filing provides granular detail on daily transactions but does not include any period-over-period comparisons or commentary on financial performance.

• · Purchases were executed on four trading venues: XMAD (Madrid), CEUX, TQEX, and AQEU.
• · The largest single-day purchase was 3,650,000 shares on 18/09/2026 on XMAD at €12.6700.
• · The highest weighted average price was €12.9668 (17/09/2026, XMAD, 100,000 shares).
• · The lowest weighted average price was €12.5928 (18/09/2026, CEUX, 1,699,345 shares).

24-09-2026

Mizuho Financial Group Inc (MHFG) announced a share repurchase program authorized on May 15, 2026 and July 30, 2026, with a maximum of 35,000,000 shares (1.4% of total shares outstanding) and an aggregate repurchase price of up to ¥200,000,000,000. As of September 18, 2026, the company had repurchased 24,352,700 shares for ¥199,999,944,900, nearly exhausting the authorized amount. All repurchased shares are scheduled to be cancelled on October 23, 2026.

• · Repurchase period runs from May 18, 2026 to September 30, 2026.
• · Cancellation of all repurchased shares scheduled for October 23, 2026.
• · Treasury stock held as of June 30, 2026: 9,294,931 shares.

24-09-2026

Hafnia Limited announced the acquisition of an additional 1.7 million shares of TORM plc, as disclosed in a press release dated September 24, 2026. The filing is a routine Form 6-K report of a foreign private issuer, with no financial results or period-over-period comparisons provided.

• · The filing is for the month of September 2026.
• · Commission File Number: 001-41996.
• · The press release is dated September 24, 2026.
• · The company's address is 10 Pasir Panjang Road, #18-01 Mapletree Business City, Singapore 117438.

24-09-2026

TruGolf Holdings, Inc. (TRUG) entered into a Separation and Settlement Agreement with departing founder Christopher Jones on September 22, 2026, providing for a $100,000 severance payment and repayment of a $1,444,000 outstanding loan with 12% interest. The company also agreed to repurchase certain franchise rights from Jones for $500,000. Concurrently, the board appointed Jay Heller, former Head of Capital Markets at Nasdaq, as an independent director. The filing also notes that approximately $1.76 million of Series A preferred stock remains outstanding, and the company has 12,065,115 Class A common shares outstanding.

• · The Separation Agreement replaces prior loan payment terms that required the loan to be repaid on demand.
• · The deferred portion of the franchise buyback is subject to acceleration if the company resells the franchise rights before the Maturity Date.
• · Christopher Jones agreed to vote all Class B common shares in accordance with board recommendations for one year.
• · Jones will be available for operational transition consulting at $100 per hour as an independent contractor.
• · Jay Heller holds a B.S. in Management Science & Economics from Kean University and has served on the board of Naoris Quantum Protocol Inc. since June 2026.
• · The Waiver and Exchange Agreement included a reset of the Series A conversion price to $1.00 per share.

24-09-2026

TSMC reported routine monthly disclosures for August 2026, including minor insider shareholding increases by two vice presidents (1,000 and 2,350 shares respectively) and significant capital appropriations totaling US$29,442 million approved by the board for machinery equipment and real estate. No pledges, asset acquisitions/dispositions, bond issuances, or share cancellations occurred during the month.

• · No pledges, asset acquisitions/dispositions, bond issuances, or share cancellations occurred in August 2026.
• · The capital appropriations are approved by the board but not yet necessarily spent; they represent planned investments.

24-09-2026

Sequans Communications completed its Bitcoin treasury exit by selling its remaining 314 Bitcoin holdings, eliminating all cryptocurrency exposure and convertible debt (except government R&D project debt). The company reported strong Q2 2026 product revenue growth of over 80% YoY and a six-month product backlog that more than tripled YoY. However, the filing does not disclose any current-period revenue or profit figures, and the company's prior reliance on Bitcoin for treasury management may raise questions about past risk management.

• · No outstanding debt except government-financed R&D projects
• · First drone design win for SDR RF transceiver in Q2 2026
• · Growing pipeline in defense, drone, and space markets
• · Convertible debt redemption completed in May 2026

24-09-2026

Group 1 Automotive Inc.'s subsidiary, Group 1 Realty, Inc., entered into a Master Credit Agreement with Bank of America, N.A. on September 23, 2026, securing a term loan facility with a draw period of up to $190,336,250. The loan is secured by real estate properties and guaranteed by Group 1 Automotive Inc. and certain subsidiaries. Proceeds will be used for general corporate purposes, including property acquisitions.

• · The loan is secured by mortgages on properties owned by Group 1 Realty, Inc., with additional properties eligible to be added as collateral during the draw period.
• · The loan is guaranteed jointly and severally by Group 1 Automotive Inc. and certain subsidiaries that operate from or own the properties.
• · Borrower may request advances up to 85% of the appraised value of all properties, subject to Bank's approval.
• · Principal amounts repaid cannot be reborrowed.
• · Properties can be released from the lien upon payment of a required release amount that maintains a loan-to-value ratio of no greater than 85%.
• · If dealership properties fall below 50% of total appraised value, Bank may require release of non-dealership properties on 30 days' notice.

24-09-2026

Jaguar Health, Inc. entered into exchange agreements with Streeterville Capital, LLC on September 23, 2026, issuing 547,898 shares of common stock in exchange for a $5,049,909.26 reduction in the outstanding balance of its secured promissory note. As of that date, the company had approximately 1,281,867 shares outstanding. The transaction reduces debt but significantly dilutes existing shareholders.

• · The exchange was conducted under the exemption from registration provided by Section 3(a)(9) of the Securities Act.
• · The 2025 Note Exchange Agreements include representations, warranties, and covenants customary for such transactions.
• · The exchange shares represent approximately 42.7% of the total shares outstanding post-exchange (547,898 / 1,281,867).

24-09-2026

AITX filed an 8-K announcing a September 24, 2026 press release titled 'AITX's RAD Updates Hardware Pricing to Reflect Rising Materials, Compute and Transportation Costs.' The pricing update is a response to rising input costs; the filing does not disclose specific price changes or financial impact, making it a routine operational update.

• · Press release attached as Exhibit 99.1 has not been filed for Section 18 purposes and is not incorporated by reference into any other SEC filing.
• · The filing explicitly states it will not be deemed an admission of materiality.

24-09-2026

Kyverna Therapeutics reported positive one-year data from its registrational trial (KYSA-8) of miv-cel (mivocabtagene autoleucel, KYV-101) in stiff person syndrome and positive longer-term follow-up data from the Phase 2 portion of its registrational trial (KYSA-6) of miv-cel in generalized myasthenia gravis (gMG). The company will host a conference call on September 24, 2026, to review the results. No specific numerical data or comparative performance metrics were disclosed in the filing.

• · The press release is furnished as Exhibit 99.1 and incorporated by reference.
• · The information is furnished under Item 7.01 and is not deemed 'filed' for SEC liability purposes.
• · The company is an emerging growth company.

24-09-2026

Caledonia Mining Corporation Plc filed a Form 6-K with the SEC on September 24, 2026, for the month of September 2026, attaching a press release dated the same day. The filing is a routine foreign issuer report and does not contain any financial results or material operational updates beyond the press release reference.

• · The filing is a Form 6-K for the month of September 2026.
• · The press release (Exhibit 99.1) is dated September 24, 2026.
• · No financial figures or operational metrics are disclosed in the filing itself.

24-09-2026

Utah Medical Products, Inc. (UTMD) announced an issuer tender offer to repurchase up to 650,000 shares of its common stock at $75.00 per share, representing approximately 20.5% of its 3,173,818 outstanding shares as of September 14, 2026. The offer is funded from the company's own resources and is intended to return capital to shareholders. Directors and executive officers collectively own 7.9% of outstanding shares (including options) and may participate in the offer, but no specific participation commitments are disclosed.

• · Directors and executive officers as a group own 228,195 shares directly (7.1%) and 25,600 options (0.8%), totaling 253,795 shares (7.9%).
• · Kevin L. Cornwell, Chairman and CEO, directly owns 188,472 shares (5.9%).
• · The offer is subject to conditions including minimum tender and regulatory approvals.
• · The tender offer expires on a date not specified in this filing; the Offer to Purchase is dated September 22, 2026.

24-09-2026

Evolution Metals & Technologies Corp. (formerly Welsbach Technology Metals Acquisition Corp.) filed an S-1/A registration statement with the SEC on September 24, 2026, covering financial results for the six months ended June 30, 2026, with comparative data for 2025. The filing includes a restatement of prior period financials and details convertible debentures and related party transactions. While the company reports revenue growth in certain segments, it also discloses a net loss and reliance on debt financing, presenting a mixed financial picture.

• · The registration statement is filed under SEC file number 333-298787.
• · The company changed its name from Welsbach Technology Metals Acquisition Corp. on June 7, 2021.
• · Fiscal year end is December 31.
• · The filing includes a restatement adjustment for previously reported financials for periods in 2024 and 2025.
• · Convertible debentures are a key financing instrument, with a maximum and minimum mentioned for the period.
• · Related party transactions and non-consolidated VIEs are disclosed.
• · The filing references a July investment agreement derivative with a probability-based measurement input.

24-09-2026

Cellyan Biotechnology Co., Ltd (formerly Hong Kong Pharma Digital Technology Holdings Ltd) announced the resignation of independent director Mike Yao Zhou, effective September 18, 2026, and the immediate appointment of Letao Zhao as his replacement. Mr. Zhao brings over 20 years of entrepreneurial and operational experience in brick-and-mortar businesses, including retail apparel and restaurant management, and will serve as an independent director, committee member, and chairperson of the Compensation Committee. The change appears routine and does not indicate any financial or operational disruption.

• · Mr. Zhou resigned from the Board and all three committees (Audit, Compensation, Nominating and Corporate Governance) effective September 18, 2026.
• · Mr. Zhao was appointed as independent director, member of the three committees, and chairperson of the Compensation Committee, effective September 18, 2026.
• · Mr. Zhao holds a bachelor's degree from Shandong University (January 2023).
• · Mr. Zhao has no family relationship with any director or executive officer and no reportable transactions with the Company in the past two years.

24-09-2026

Lufax Holding Ltd filed a Form 6-K with the SEC on September 24, 2026, announcing that it has fulfilled the resumption guidance required by The Stock Exchange of Hong Kong Limited and that trading of its shares on the Hong Kong Stock Exchange will resume. The filing, signed by CEO Xiang Ji, marks a significant step toward normalizing the company's listing status after a suspension.

• · The resumption of trading on the Hong Kong Stock Exchange follows fulfilment of the exchange's resumption guidance.
• · The filing was made under cover of Form 6-K for the month of September 2026.
• · The company's SEC file number is 001-39654.

24-09-2026

Lion Group Holding Ltd. (LGHL) notes an update from Skyfame Realty (Holdings) Limited (in liquidation) regarding its resumption progress on the Hong Kong Stock Exchange. Skyfame submitted a resumption proposal on September 17, 2026, and the High Court of Hong Kong granted leave to convene a scheme creditors meeting, expected in late October/early November 2026, with a sanction hearing tentatively scheduled for November 20, 2026. However, there is no assurance that any restructuring will be completed or that trading in Skyfame's shares will resume, and the filing contains no financial figures or period-over-period comparisons.

• · Skyfame submitted a resumption proposal to HKEX on September 17, 2026.
• · Skyfame applied for an extension of the remedial period to December 31, 2026.
• · The High Court of Hong Kong granted leave for Skyfame to convene a scheme creditors meeting on September 18, 2026.
• · The scheme meeting is expected in late October or early November 2026.
• · The sanction hearing is tentatively scheduled for November 20, 2026.
• · Lion Wealth Management Limited entered into an exclusivity agreement with Skyfame on April 10, 2026.

24-09-2026

Lead Real Estate Co., Ltd has furnished a notice of its 26th Ordinary General Meeting of Shareholders, to be held on September 29, 2026 in Tokyo, Japan. The filing is a routine procedural disclosure under SEC Rule 13a-16 and does not contain any financial results, operational updates, or performance metrics.

24-09-2026

Mesoblast Ltd filed a Form 6-K with the SEC on September 24, 2026, attaching a press release that was also filed with the Australian Securities Exchange. The filing itself does not contain any financial results, quantitative data, or specific business updates beyond the incorporation of the press release by reference.

• · The filing is a Form 6-K (Foreign Issuer Report) dated September 24, 2026.
• · The press release was first filed with the Australian Securities Exchange.
• · No financial figures, business milestones, or regulatory actions are disclosed in the 6-K body.

24-09-2026

AtlasClear Holdings, Inc. filed its 10-K for the fiscal year ended June 30, 2026, reporting total revenues of $20.05M, up 84.7% from $10.86M in FY2025, driven by a surge in stock locate fees ($6.78M vs $0.29M) and commissions ($9.25M vs $5.94M). However, total expenses rose 89.1% to $29.82M, leading to a loss from operations of $9.77M, nearly double the prior year's $4.92M loss. Net income fell 65.9% to $1.96M from $5.75M, as a large non-cash gain on earnout liability ($11.1M) offset operating losses but was much smaller than prior-year fair value gains.

• · Stock locate fees surged from $0.29M to $6.78M, a 2,258% increase, but this may be volatile and non-recurring.
• · Clearing fees declined 35.1% YoY to $2.06M, and vetting fees fell 4.7% to $1.39M, indicating weakness in core clearing services.
• · Compensation expense nearly doubled (+90.7%) to $11.73M, and data processing costs rose 169.4% to $5.67M, outpacing revenue growth.
• · The company reported a non-cash gain of $11.11M from change in fair value of earnout liability, which significantly boosted net income.
• · Interest expense decreased 37.1% to $5.08M, but the company still carries significant indebtedness and convertible notes.
• · The company faces multiple risk factors including potential default on convertible notes, going concern uncertainty, and failure to complete pending acquisitions.
• · AtlasClear is subject to extensive SEC and FINRA regulation, and its common stock is listed on NYSE American with compliance risks.

24-09-2026

Lantern Pharma Inc. hosted a live webinar on September 23, 2026, to discuss its Open-Medicine AI multi-agentic AI platform for drug development. The company furnished a presentation as Exhibit 99.1 and provided a replay link. No financial results or material operational updates were disclosed.

• · Webinar replay available at https://youtu.be/s7br8vjMk4s and on the investors section of the company's website.
• · Presentation furnished as Exhibit 99.1 to the Form 8-K.

24-09-2026

Afya Limited has entered into a merger agreement with Yduqs Participações S.A., as disclosed in a Form 6-K filed with the SEC on September 24, 2026. The merger is a significant strategic move for Afya, combining two major players in the Brazilian education sector. No financial terms or performance metrics were disclosed in this filing.

• · The merger agreement was signed on or before September 23, 2026.
• · The filing is a Form 6-K submitted to the SEC for the month of September 2026.
• · Afya's principal executive offices are located in Belo Horizonte, Minas Gerais, Brazil.

24-09-2026

Vale S.A. announced the partial resumption of operations at its Fábrica Mine in Ouro Preto, Minas Gerais, following authorization from the Court of Justice of the State of Minas Gerais and a Commitment Agreement with the State Public Prosecutor's Office and the State of Minas Gerais. The resumption will comply with safety, environmental, and licensing requirements, and the company reaffirmed that its current production guidance remains unchanged.

• · The Fábrica Mine is located in Ouro Preto, Minas Gerais, Brazil.
• · Authorization was granted by the Court of Justice of the State of Minas Gerais.
• · The Commitment Agreement was entered into by Vale, the State Public Prosecutor's Office, and the State of Minas Gerais.
• · The resumption does not change Vale's current production guidance.

24-09-2026

Key Tronic Corporation filed a definitive proxy statement (DEF 14A) for its 2026 Annual Meeting of Shareholders scheduled for October 29, 2026. The meeting will include the election of seven directors, an advisory vote on executive compensation and on the frequency of such votes, and ratification of Baker Tilly US, LLP as auditor for fiscal year 2027. As of the record date of September 14, 2026, there were 11,060,793 shares of common stock outstanding.

• · Annual Meeting date: October 29, 2026 at 10:00 a.m. Pacific Time at 4424 N. Sullivan Road – Upper Level, Spokane Valley, Washington 99216.
• · Proxy materials first mailed to shareholders on or about October 1, 2026.
• · Record date for voting: close of business on September 14, 2026.
• · Advisory vote on frequency of future executive compensation votes (Proposal 3) – the frequency receiving the greatest number of votes cast will be approved.
• · Broker non-votes will have no effect on Proposals 2, 3, or 4, but will have the practical effect of voting against a nominee in the director election.
• · Ronald F. Klawitter has been Chair of the Board since January 2024.

24-09-2026

Independence Realty Trust, Inc. (IRT) filed an S-4 registration statement on September 23, 2026, in connection with its proposed merger with CSR (CSR). The merger will be effected through a stock-for-stock exchange, with each share of CSR Common Stock converting into newly issued IRT Common Stock at a fixed Exchange Ratio. The transaction is subject to stockholder approvals from both companies, regulatory clearances, and other customary conditions, with a termination date of June 30, 2027. Risks highlighted include potential failure to consummate the merger, diversion of management attention, and the fact that the Exchange Ratio will not be adjusted for changes in market prices, exposing CSR shareholders to market risk on the consideration received.

• · The merger must be consummated by June 30, 2027, or either party may terminate the agreement.
• · Termination fees are payable by CSR or IRT under certain circumstances, such as CSR accepting a superior proposal.
• · IRT has the right to defer closing until lender consents for certain CSR mortgage loans are obtained, but no later than June 30, 2027.
• · The Exchange Ratio may be adjusted for stock splits, reverse stock splits, combinations, subdivisions, reclassifications, and REIT dividends declared before closing, but not for regular distributions or market price changes.
• · CSR shareholder approval requires the affirmative vote of holders of at least a majority of outstanding CSR Common Stock.
• · The filing incorporates by reference IRT's and CSR's Quarterly Reports on Form 10-Q for the period ended June 30, 2026, and Annual Reports on Form 10-K for the year ended December 31, 2025.

24-09-2026

News Corp filed an 8-K to disclose its daily stock repurchase transactions under its existing $1 billion buyback program, as required by the Australian Securities Exchange (ASX). The filing includes exhibits with ASX disclosures and forward-looking statements regarding the company's intent to repurchase Class A and Class B common stock. No financial results or material operational changes were reported.

• · The repurchase program covers both Class A common stock (ticker: NWSA) and Class B common stock (ticker: NWS), both listed on The Nasdaq Global Select Market.
• · The company is required to provide daily disclosure of repurchase transactions to the ASX under ASX rules.
• · The filing includes forward-looking statements regarding the company's intent to repurchase shares from time to time, subject to market conditions and other factors.

24-09-2026

Aurora Cannabis Inc. filed a Form 6-K with the SEC on September 24, 2026, attaching a news release dated September 23, 2026. The filing is a routine foreign issuer report and does not contain any financial results or material operational updates beyond the existence of the press release.

• · The filing is made under Form 40-F (Canadian issuer).
• · The news release is dated September 23, 2026, and is attached as Exhibit 99.1.

24-09-2026

InnovAge Holding Corp. filed a 424B4 prospectus supplement for a secondary offering of 10,000,000 shares of common stock by selling security holders, with an underwriters' option for an additional 1,500,000 shares. The public offering price is $9.25 per share, totaling $92.5 million, with the company receiving no proceeds. The offering price represents a discount of approximately 12.7% from the last reported sale price of $10.60 on September 21, 2026, and the offering is expected to close on September 24, 2026.

• · The offering is part of a shelf registration process on Form S-3.
• · The underwriters have a 30-day option to purchase up to an additional 1,500,000 shares from selling security holders.
• · The company will not receive any proceeds from the offering, including from the underwriters' option.
• · The offering is expected to close on or about September 24, 2026.
• · The prospectus supplement is dated September 22, 2026.
• · The company's common stock is listed on The Nasdaq Global Select Market under the symbol 'INNV'.
• · The company is a 'controlled company' and its operations are concentrated in California and Colorado.
• · Risk factors include potential reductions in PACE reimbursement rates and ongoing civil investigative demands by federal and state agencies.

24-09-2026

New Pacific Metals Corp. filed a Form 6-K with the SEC for September 2026, attaching a news release dated September 23, 2026. The filing itself contains no financial data or operational metrics, only a cover page and signature. The materiality of the underlying news release cannot be assessed from the filing alone.

• · Filing is a Form 6-K for the month of September 2026.
• · Exhibit 99.1 is a news release dated September 23, 2026, but its content is not included in this filing.
• · The registrant files annual reports under Form 40-F.

24-09-2026

AMC Entertainment Holdings, Inc. filed an 8-K on September 23, 2026, announcing the pricing of a First Lien Notes Offering and a New 1L Term Loan Facility. The proceeds are intended to fund a tender offer for its AMC Secured Notes and a conditional full redemption of its Muvico 1.5L Notes, as part of ongoing balance sheet strengthening. The filing contains extensive forward-looking statements highlighting risks including significant indebtedness, the need for additional liquidity, and the potential for an in-court or out-of-court restructuring if operating revenues do not normalize.

• · The filing does not constitute a notice of redemption of the Muvico 1.5L Notes or the AMC Secured Notes.
• · The tender offer is described in an Offer to Purchase dated September 21, 2026.
• · The press release announcing the pricing is dated September 23, 2026, and is filed as Exhibit 99.1.
• · The company explicitly warns that if it cannot achieve normalized operating revenues, it may seek an in-court or out-of-court restructuring of its liabilities.

24-09-2026

First Merchants Corporation priced a $100 million offering of 6.750% Fixed-to-Floating Rate Subordinated Notes due 2036, expected to close on September 25, 2026. The notes will bear a fixed rate of 6.750% until October 1, 2031, then reset quarterly to Three-Month Term SOFR plus 202 basis points. Net proceeds will be used for general corporate purposes, including common share repurchases, and the notes are intended to qualify as Tier 2 capital. Piper Sandler is the sole book-running manager, with Keefe, Bruyette & Woods, Hovde Group, and Brean Capital as co-managers.

• · Notes mature on October 1, 2036, unless earlier redeemed.
• · Company may redeem notes on or after October 1, 2031 at 100% of principal plus accrued interest.
• · Interest payable semiannually from April 1, 2027 until October 1, 2031, then quarterly.
• · Registration statement File No. 333-298983 filed with the SEC.
• · Proceeds intended for general corporate purposes, including common share repurchases.
• · Notes intended to qualify as Tier 2 capital for regulatory purposes.

24-09-2026

Frazier Life Sciences Acquisition Corp. II filed an S-1 registration statement with the SEC on September 23, 2026, for an initial public offering. The SPAC is offering 7,500,000 public shares at an anticipated trust account value of $10.00 per share, with a total trust amount initially expected to be $75,000,000. The filing details redemption rights for public shareholders in connection with a future business combination, including mechanisms via shareholder vote or tender offer, and notes that sponsor, officers, and directors have agreed to waive redemption rights on founder and private placement shares.

• · The filing is a registration statement for a SPAC IPO, not a business combination announcement.
• · The company is incorporated in the Cayman Islands.
• · Founder shares and private placement shares are not subject to redemption rights in a business combination.
• · The sponsor, officers, and directors have agreed to vote their founder shares, private placement shares, and any public shares acquired in favor of the initial business combination.
• · If a quorum of one-third of shares is present, the founder and private placement shares alone would be sufficient to approve an ordinary resolution business combination.
• · Redemptions may be conducted via proxy solicitation (shareholder vote) or tender offer, at the company's discretion.
• · The company intends to require physical or electronic delivery of shares for redemption, with a deadline up to two business days before the shareholder vote.
• · The filing does not disclose a specific target company or business combination timeline.

24-09-2026

IDT Corporation announced a quarterly cash dividend of $0.07 per share, payable on October 14, 2026, to stockholders of record as of October 5, 2026. The dividend was declared by the Board of Directors on September 22, 2026. This is a routine dividend declaration with no negative or flat metrics reported.

• · Dividend record date: October 5, 2026
• · Dividend payment date: October 14, 2026
• · Class B common stock, par value $0.01 per share, listed on NYSE under ticker IDT